A Cross-sectional Cohort Study to Assess Long-term Neurocognitive and Psychiatric Symptoms of Mefloquine Use in Veterans.
Matthew J ReinhardJeremy E ChesterCharity B BrenemanImmanuel B H SamuelMichelle K PriscoTerra D VincentPeter D RummShanna R SmithJohn P BarrettPublished in: Military medicine (2022)
This study suggests that mefloquine use by veterans referred for intensive evaluation of their military deployment exposures and health was not associated with increased, long-term, neurocognitive/psychiatric symptoms compared to unexposed veterans.